Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study

Published:2020-10 Issue:1 Volume:183 Page:4-10
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Au Lewis,Boos Laura Amanda,Swerdlow Anthony,Byrne Fiona,Shepherd Scott T.C.,Fendler Annika,Turajlic Samra

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference18 articles.

1. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study;Lancet,2020

2. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak;Dai;Cancer Discov.,2020

3. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study;Garassino;Lancet Oncol.,2020

4. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals;Grifoni;Cell,2020

5. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study;Kuderer;Lancet,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study;International Journal of Clinical Oncology;2024-02-21

2. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study;2023-11-29

3. Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination;Expert Review of Vaccines;2023-11-10

4. Targeting CD47 as a therapeutic strategy: A common bridge in the therapy of COVID-19-related cancers;Heliyon;2023-07

5. Efficacy and safety of COVID-19 vaccines for patients with spinal tumors receiving denosumab treatment: An initial real−clinical experience study;Frontiers in Oncology;2023-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3